AGIO logo

Agios Pharmaceuticals (AGIO)

Profile

Full Name

Agios Pharmaceuticals, Inc.

Ticker Symbol

AGIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2013

Indexes

Not included

Website

http://www.agios.com

Employees

486

Key Details

Price

$29.26(+3.14%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$36.50M(+36.07% YoY)

Annual EPS

$11.64(+283.89% YoY)

PE ratio

2.58

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$29.26
AGIO price is $29.26

30-Day Relative Volume

0.56
AGIO 30-day relative volume is 0.56

Price Performance

Price Most recent change

+3.14%
AGIO price was up +3.14% on Apr 24, 2025

Price YTD change

-10.96%
AGIO price is down -10.96% since January 1st

Price 1-year change

-7.61%
AGIO price is down -7.61% year-on-year

Price 3-year change

+17.27%
AGIO price is up +17.27% over the past 3 years

Price Range

Price All-time high

$138.85
AGIO price is currently -78.93% below its historical high of $138.85

Price 3-year low

$16.75
AGIO price is currently +74.69% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.68B
AGIO market capitalization is $1.68 billion

Market cap 3-year change

+22.64%
AGIO market capitalization is up +22.64% over the past 3 years

Market cap All-time high

$5.73B
AGIO market capitalization is currently -70.77% below its historical high of $5.73 billion

Market cap sector rank

80.94%
AGIO market capitalization is higher than 80.94% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.92%
AGIO shares outstanding is up +0.92% year-on-year

Shares Outstanding 3-Year Change

+4.6%
AGIO shares outstanding is up +4.6% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.08
AGIO beta is 1.08

200-day SMA

$40.77
AGIO price is currently -28.23% below its 200-day simple moving average

50-day SMA

$30.79
AGIO price is currently -4.98% below its 50-day simple moving average

RSI

52.73
AGIO 14-day relative strength index is 52.73

Volume

0.56
AGIO 30-day relative volume is 0.56

ATR

$1.50
AGIO average true range is $1.50

10-day Historical Volatility

44.38%
AGIO 10-day historical volatility is 44.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$36.50M
AGIO annual revenue is $36.50 million

Revenue Analysts estimate

$51.00M
AGIO annual revenue is currently -28.44% lower than the consensus analysts' forecast

Revenue 1-year change

+36.07%
AGIO annual revenue is up +36.07% year-on-year

Revenue Sector rank

42.55%
AGIO annual revenue is higher than 42.55% of companies in Healthcare sector

EPS

EPS

$11.64
AGIO annual earnings per share is $11.64

EPS Analysts estimate

-$7.19
AGIO annual earnings per share is currently -261.89% lower than the consensus analysts' forecast

EPS 1-year change

+283.89%
AGIO annual earnings per share is up +283.89% year-on-year

EPS Sector rank

98.5%
AGIO annual earnings per share is higher than 98.5% of companies in Healthcare sector

Profit

Gross profit

$32.33M
AGIO annual gross profit is $32.33 million

Gross margin

88.59%
AGIO annual gross profit margin is 88.59%

Operating profit

-$425.74M
AGIO annual operating income is -$425.74 million

Operating margin

-1166.47%
AGIO annual operating profit margin is -1166.47%

Net income

$673.73M
AGIO annual net profit is $673.73 million

Net margin

-
AGIO annual net profit margin value is unknown

Expenses

Total expenses

$462.24M
AGIO annual total expenses is $462.24 million

Operating expenses

$458.07M
AGIO annual total operating expenses is $458.07 million

Cost of goods sold

$4.17M
AGIO annual cost of goods sold is $4.17 million

Selling, general & administrative expenses

$156.78M
AGIO annual SGA is $156.78 million

Depreciation and amortization

$5.65M
AGIO annual depreciation & amortization is $5.65 million

Interest expense

-
AGIO annual interest expense value is unknown

Income tax

$44.24M
AGIO annual income tax is $44.24 million

EBIT & EBITDA

EBIT

-$425.74M
AGIO annual earnings before interest & taxes is -$425.74 million

EBITDA

-$420.08M
AGIO annual EBITDA is -$420.08 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.66B
AGIO annual total assets is $1.66 billion

Non current assets

$697.60M
AGIO annual long term assets is $697.60 million

Current assets

$965.60M
AGIO annual total current assets is $965.60 million

Cash and cash equivalents

$76.25M
AGIO annual cash & cash equivalents is $76.25 million

Accounts receivable

$4.11M
AGIO annual accounts receivable is $4.11 million

Inventory

$27.62M
AGIO annual inventory is $27.62 million

Liabilities

Total liabilities

$122.24M
AGIO annual total liabilities is $122.24 million

Long term liabilities

$41.09M
AGIO annual total long term liabilities is $41.09 million

Current liabilities

$81.16M
AGIO annual total current liabilities is $81.16 million

Accounts payable

$16.64M
AGIO annual accounts payable is $16.64 million

Debt

Total debt

$56.99M
AGIO annual total debt is $56.99 million

Total debt 1-year change

-20.85%
AGIO annual total debt is down -20.85% year-on-year

Long term debt

$40.21M
AGIO annual long term debt is $40.21 million

Short term debt

$16.78M
AGIO annual short term debt is $16.78 million

Equity & Capital

Shareholders equity

$1.54B
AGIO annual stockholders equity is $1.54 billion

Book value

$1.54B
AGIO annual book value is $1.54 billion

Retained earnings

-$148.92M
AGIO annual retained earnings is -$148.92 million

Working capital

$884.44M
AGIO annual working capital is $884.44 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$389.84M
AGIO annual cash flow from operations is -$389.84 million

Cash from operations 1-year change

-31.68%
AGIO annual cash flow from operations is down -31.68% year-on-year

Cash from investing

$363.44M
AGIO annual cash flow from investing activities is $363.44 million

Cash from investing 1-year change

+51.7%
AGIO annual cash flow from investing activities is up +51.7% year-on-year

Cash from financing

$14.44M
AGIO annual cash flow from financing activities is $14.44 million

Cash from financing 1-year change

+165.82%
AGIO annual cash flow from financing activities is up +165.82% year-on-year

CAPEX

CAPEX

$1.69M
AGIO annual capital expenditures is $1.69 million

CAPEX 1-year change

-90.89%
AGIO annual capital expenditures is down -90.89% year-on-year

Free Cash Flow

Free cash flow

-$391.53M
AGIO annual free cash flow is -$391.53 million

Free cash flow 1-year change

-24.47%
AGIO annual free cash flow is down -24.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

88.59%
AGIO annual gross profit margin is 88.59%

Operating margin

-1166.47%
AGIO annual operating profit margin is -1166.47%

Net margin

-
AGIO annual net profit margin value is unknown

ROA & ROE

ROA

51.82%
AGIO annual return on assets is 51.82%

ROE

57.29%
AGIO annual return on equity is 57.29%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

2.58
AGIO price to earnings ratio is 2.58

PE ratio Sector rank

3.92%
AGIO price to earnings ratio is higher than 3.92% of companies in Healthcare sector

PB Ratio

PB ratio

1.09
AGIO price to book ratio is 1.09

PB ratio Sector rank

44.4%
AGIO price to book ratio is higher than 44.4% of companies in Healthcare sector

PS Ratio

PS ratio

45.93
AGIO price to sales ratio is 45.93

PS ratio Sector rank

90.78%
AGIO price to sales ratio is higher than 90.78% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.66B
AGIO enterprise value is $1.66 billion

Enterprise value Sector rank

80.23%
AGIO enterprise value is higher than 80.23% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.94
AGIO EV/EBITDA is -3.94

EV/EBITDA Sector rank

23.39%
AGIO EV/EBITDA is higher than 23.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

11.90
AGIO annual current ratio is 11.90

Quick ratio

11.56
AGIO annual quick ratio is 11.56

Leverage

Debt to equity

0.00
AGIO annual debt to equity ratio is 0.00

Interest coverage ratio

-
AGIO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
AGIO piotroski f-score is 3

Altman Z-Score

7.92
AGIO altman z-score is 7.92

Analyst ratings

Recent major analysts updates

Feb 24, 25 HC Wainwright & Co.
Buy
Dec 18, 24 Cantor Fitzgerald
Overweight
Dec 10, 24 RBC Capital
Outperform
Dec 9, 24 Scotiabank
Sector Outperform
Nov 1, 24 Scotiabank
Sector Outperform
Oct 16, 24 Scotiabank
Sector Outperform
Sep 27, 24 Leerink Partners
Market Perform
Sep 20, 24 Cantor Fitzgerald
Overweight
Sep 19, 24 RBC Capital
Outperform
Aug 2, 24 RBC Capital
Outperform

Institutional Ownership

Similar stocks

ARWR logo
Arrowhead Pharmaceuticals (ARWR)
IDYA logo
IDEAYA Biosciences (IDYA)
HRMY logo
Harmony Biosciences Holdings (HRMY)
BEAM logo
Beam Therapeutics (BEAM)
ATRC logo
AtriCure (ATRC)
ATEC logo
Alphatec Holdings (ATEC)
CGON logo
CG Oncology (CGON)
BCRX logo
BioCryst Pharmaceuticals (BCRX)
GLPG logo
Galapagos NV (GLPG)
  • What is the ticker symbol for Agios Pharmaceuticals?
  • Does Agios Pharmaceuticals pay dividends?
  • What sector is Agios Pharmaceuticals in?
  • What industry is Agios Pharmaceuticals in?
  • What country is Agios Pharmaceuticals based in?
  • When did Agios Pharmaceuticals go public?
  • Is Agios Pharmaceuticals in the S&P 500?
  • Is Agios Pharmaceuticals in the NASDAQ 100?
  • Is Agios Pharmaceuticals in the Dow Jones?
  • When was Agios Pharmaceuticals's last earnings report?
  • When does Agios Pharmaceuticals report earnings?
  • Should I buy Agios Pharmaceuticals stock now?

What is the ticker symbol for Agios Pharmaceuticals?

The ticker symbol for Agios Pharmaceuticals is NASDAQ:AGIO

Does Agios Pharmaceuticals pay dividends?

No, Agios Pharmaceuticals does not pay dividends

What sector is Agios Pharmaceuticals in?

Agios Pharmaceuticals is in the Healthcare sector

What industry is Agios Pharmaceuticals in?

Agios Pharmaceuticals is in the Biotechnology industry

What country is Agios Pharmaceuticals based in?

Agios Pharmaceuticals is headquartered in United States

When did Agios Pharmaceuticals go public?

Agios Pharmaceuticals's initial public offering (IPO) was on July 24, 2013

Is Agios Pharmaceuticals in the S&P 500?

No, Agios Pharmaceuticals is not included in the S&P 500 index

Is Agios Pharmaceuticals in the NASDAQ 100?

No, Agios Pharmaceuticals is not included in the NASDAQ 100 index

Is Agios Pharmaceuticals in the Dow Jones?

No, Agios Pharmaceuticals is not included in the Dow Jones index

When was Agios Pharmaceuticals's last earnings report?

Agios Pharmaceuticals's most recent earnings report was on Feb 13, 2025

When does Agios Pharmaceuticals report earnings?

The next expected earnings date for Agios Pharmaceuticals is May 1, 2025

Should I buy Agios Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page